Long-Term Outcome of Patients with Locally Advanced Clinically Unresectable Esophageal Cancer Undergoing Conversion Surgery after Induction Chemotherapy with Docetaxel Plus Cisplatin and 5-Fluorouracil.
Tetsuya AbeEiji HigakiTakahiro HosoiTakuya NagaoHideaki BandoShigenori KadowakiKei MuroTsutomu TanakaMasahiro TajikaYasumasa NiwaYasuhiro ShimizuPublished in: Annals of surgical oncology (2020)
Induction DCF chemotherapy and subsequent CS show acceptable toxicity and offer the chance of long-term survival in patients with locally advanced clinically unresectable esophageal cancer.